Genetic Signatures welcomes Mike Aicher as Executive Director – U.S. Operations

Genetic Signatures has recently appointed Mike Aicher to the company’s Board of Directors as Executive Director – U.S. Operations.

Mr. Aicher was CEO of National Genetics Institute (NGI), a company he co-founded in 1991, that later became a wholly owned subsidiary of Laboratory Corporation of America (LabCorp). More recently, Mr. Aicher led LabCorp’s Western Division and was previously responsible for the company’s Esoteric Business Units, which generated more than $1 billion in annual revenue. Prior to NGI, Mr. Aicher served in a number of executive leadership roles at Central Diagnostics Laboratory. He is certified by the University of California at Berkeley as a Global Biotechnology Executive and is a recipient of Ernst & Young’s “Entrepreneur of the Year” award for emerging technologies. Mr. Aicher received a B.S. in Business Administration from the University of Redlands and an M.B.A. in Economics from Columbus University.

According to Dr. John Melki, CEO of Genetic Signatures, this is a significant step forward for the company. “We are pleased to welcome Mike to our Board as Executive Director – U.S. Operations. His extensive experience of the global clinical diagnostic testing market will assist us to accelerate our efforts both locally and globally” said Dr Melki.

“Real-time PCR infectious pathogen detection allows more sensitive testing for a larger number of pathogens in a shorter time frame compared to traditional methods ” said Mr Aicher. “John and the team at Genetic Signatures are developing a comprehensive range of real-time infectious pathogen detection kits. Their early success shows the increased demand for tests of this kind. I am thrilled to be joining the team at this exciting time.”